Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach
Juliana H. Azambuja, Roselena Silvestri Schuh, Luana Roberta Michels, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 2, pp. 635-649
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Glioma targeted therapy: insight into future of molecular approaches
Keyang Yang, Zhijing Wu, Hao Zhang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 483
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
Sangeeta Goswami, Thomas Walle, Andrew Cornish, et al.
Nature Medicine (2019) Vol. 26, Iss. 1, pp. 39-46
Open Access | Times Cited: 296
Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment
Pablo Graván, Aixa Aguilera-Garrido, Juan Antonio Marchal, et al.
Advances in Colloid and Interface Science (2023) Vol. 314, pp. 102871-102871
Open Access | Times Cited: 64
Nucleic acid drug vectors for diagnosis and treatment of brain diseases
Zhiguo Lü, Jie Shen, H. J. Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 61
Theranostic application of nanoemulsions in chemotherapy
Bapi Gorain, Hira Choudhury, Anroop B. Nair, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 7, pp. 1174-1188
Closed Access | Times Cited: 124
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
Shiv Bahadur, Dinesh M. Pardhi, Jarkko Rautio, et al.
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1230-1230
Open Access | Times Cited: 116
Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
Franciele Aline Bruinsmann, Gustavo Richter Vaz, Aline de Cristo Soares Alves, et al.
Molecules (2019) Vol. 24, Iss. 23, pp. 4312-4312
Open Access | Times Cited: 100
Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
Sepideh Mirzaei, Mahmood Khaksary Mahabady, Amirhossein Zabolian, et al.
Life Sciences (2021) Vol. 275, pp. 119368-119368
Closed Access | Times Cited: 89
Nanoemulsions: Formulation, characterization, biological fate, and potential role against COVID-19 and other viral outbreaks
Hossam H. Tayeb, Raed I. Felimban, Sarah Almaghrabi, et al.
Colloids and Interface Science Communications (2021) Vol. 45, pp. 100533-100533
Open Access | Times Cited: 61
Nanoemulsion applications in photodynamic therapy
Saeid Moghassemi, Arezoo Dadashzadeh, Ricardo Bentes Azevedo, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 164-173
Closed Access | Times Cited: 51
Current Progress in Cancer Treatment Using Nanomaterials
Ruirui Zhu, Fangyuan Zhang, Yudong Peng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 48
Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors’ Cancer Stem Cells: Current Knowledge and Future Perspectives
Luana Abballe, Zaira Spinello, Celeste Antonacci, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 505-505
Open Access | Times Cited: 30
Nasal administration of a temozolomide-loaded thermoresponsive nanoemulsion reduces tumor growth in a preclinical glioblastoma model
Luana Roberta Michels, Flávia Nathiely Silveira Fachel, Roselena Silvestri Schuh, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 343-357
Closed Access | Times Cited: 26
Nose-to-Brain Targeting via Nanoemulsion: Significance and Evidence
Shashi Kiran Misra, Kamla Pathak
Colloids and Interfaces (2023) Vol. 7, Iss. 1, pp. 23-23
Open Access | Times Cited: 23
Ultrasound‐Activated Piezoelectric Nanoparticles Trigger Microglia Activity Against Glioblastoma Cells
Margherita Montorsi, Carlotta Pucci, Daniele De Pasquale, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 18
Open Access | Times Cited: 11
Adenosinergic Signalling in Cervical Cancer Microenvironment
Isabele Cristiana Iser, Ana Paula Santin Bertoni, Liziane Raquel Beckenkamp, et al.
Expert Reviews in Molecular Medicine (2025) Vol. 27
Closed Access | Times Cited: 1
Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches
Eilam Yeini, Paula Ofek, Nitzan Albeck, et al.
Advanced Therapeutics (2020) Vol. 4, Iss. 1
Open Access | Times Cited: 52
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
Sepideh Mirzaei, Mohammad Gholami, Hui Li Ang, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3348-3348
Open Access | Times Cited: 44
Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery
Sherif Ashraf Fahmy, Alyaa Dawoud, Yousra Ahmed Zeinelabdeen, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5244-5244
Open Access | Times Cited: 34
Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression
Leonardo Delello Di Filippo, Jonatas Lobato Duarte, Juliana H. Azambuja, et al.
International Journal of Pharmaceutics (2022) Vol. 618, pp. 121682-121682
Closed Access | Times Cited: 32
Exploring intranasal drug delivery via nanocarriers: A promising glioblastoma therapy
Vishawambhar Deshmukh, Nida Sayed Pathan, Niladri Haldar, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 245, pp. 114285-114285
Closed Access | Times Cited: 7
Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity
Juliana H. Azambuja, Nils Ludwig, Elizandra Braganhol, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5698-5698
Open Access | Times Cited: 47
Blockade of CD73 delays glioblastoma growth by modulating the immune environment
Juliana H. Azambuja, Roselena Silvestri Schuh, Luana Roberta Michels, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 9, pp. 1801-1812
Open Access | Times Cited: 47
Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review
Wei Chen, Lingfei Jiang, Hu Y, et al.
Journal of Controlled Release (2021) Vol. 340, pp. 342-360
Closed Access | Times Cited: 34
Advances in Nanomedicines: A Promising Therapeutic Strategy for Ischemic Cerebral Stroke Treatment
Jun Li, Fei Xie, Xuemei Ma
Nanomedicine (2024) Vol. 19, Iss. 9, pp. 811-835
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top